Yeast Systematic Name | Yeast Symbol | SGDID | Analog Name | Analog Description | EC | Organism | Disease | Structure | Uniprot | Human ID | Human Symbol | HHsearch Probability | HHsearch E_value | HHsearch P_value | HHsearch Score | Flag Disease related | Flag Homo sapiens | Flag Mus musculus | Flag Danio rerio | Flag Drosophila melanogaster | Flag Caenorhabditis elegans | Flag Arabidopsis thaliana | Flag Escherichia coli |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
YHR207C | SET5 | SGDID:S000001250 | RBCMT |
Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplastic (EC 2.1.1.127) ([Fructose-bisphosphate aldolase]-lysine N-methyltransferase) (EC 2.1.1.259) ([Ribulose-bisphosphate carboxylase]-lysine N-methyltransferase) (PsLSMT) (RuBisCO LSMT) (RuBisCO methyltransferase) (rbcMT) |
2.1.1.127,2.1.1.259, | Pisum sativum | 2h21_b | Q43088 | 98.60 | 8.00E-12 | 7.40E-16 | 129.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YHR207C | SET5 | SGDID:S000001250 | NSD1 ARA267 KMT3B |
Histone-lysine N-methyltransferase, H3 lysine-36 specific (EC 2.1.1.357) (Androgen receptor coactivator 267 kDa protein) (Androgen receptor-associated protein of 267 kDa) (H3-K36-HMTase) (Lysine N-methyltransferase 3B) (Nuclear receptor-binding SET domain-containing protein 1) (NR-binding SET domain-containing protein) |
2.1.1.357 | Homo sapiens | Heart Disease,Seizure Disorder,Kleefstra Syndrome,Pectus Carinatum,Deletion 5q35,Overgrowth Syndrome,Alpha Thalassemia-X-Linked Intellectual Disability Syndrome,Leukemia,5q35 Microduplication Syndrome,Cryptorchidism, Unilateral Or Bilateral,Leukemia, Acute Myeloid,Hereditary Spastic Paraplegia,Ganglioglioma,Spastic Paraplegia 8,Hyperinsulinemic Hypoglycemia,Wilms Tumor Predisposition,Myeloid Leukemia,Pre-Eclampsia,Patent Foramen Ovale,Marshall-Smith Syndrome,Farsightedness,Microcephaly,Weaver Syndrome,Sotos Syndrome 1,Alacrima, Achalasia, And Mental Retardation Syndrome,Cleft Palate, Isolated,Disease Of Mental Health,Kleefstra Syndrome 1,Alpha-Thalassemia,Developmental And Epileptic Encephalopathy 2,Beckwith-Wiedemann Syndrome,Lipedema,Cornelia De Lange Syndrome 5,Neuropathy, Hereditary Sensory, Type Ie,Myelodysplastic Syndrome,Preeclampsia/Eclampsia 1,Uvula, Bifid,Williams-Beuren Syndrome,Hypertelorism,Wolf-Hirschhorn Syndrome,Patent Ductus Arteriosus 1,Kabuki Syndrome 1,Scoliosis,Autosomal Dominant Non-Syndromic Intellectual Disability,Omphalocele,Macroglossia,Autism,Childhood Acute Myeloid Leukemia |
3ooi_a | Q96L73 | ENSG00000165671 | NSD1 | 97.40 | 1.40E-07 | 1.30E-11 | 88.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR207C | SET5 | SGDID:S000001250 | A612L |
A612L |
Paramecium bursaria | 2g46_b | O41094 | 97.00 | 9.00E-07 | 8.70E-11 | 71.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YHR207C | SET5 | SGDID:S000001250 | SETD3 C14orf154 |
Actin-histidine N-methyltransferase (EC 2.1.1.85) (SET domain-containing protein 3) (hSETD3) |
2.1.1.85 | Homo sapiens | Meier-Gorlin Syndrome 1 |
6icv_b | Q86TU7 | ENSG00000183576 | SETD3 | 98.70 | 1.90E-12 | 1.80E-16 | 135.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR207C | SET5 | SGDID:S000001250 | PRDM16 KIAA1675 MEL1 PFM13 |
Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.367) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1) |
2.1.1.367 | Homo sapiens | Cerebellar Ataxia, Nonprogressive, With Mental Retardation,Epilepsy, Familial Temporal Lobe, 2,Migraine With Or Without Aura 1,Chronic Myelomonocytic Leukemia,Hypertrophic Cardiomyopathy,Familial Isolated Dilated Cardiomyopathy,Leukemia,Migraine Without Aura,Dilated Cardiomyopathy,Migraine With Aura,Complex Chromosomal Rearrangement,Myeloid Leukemia,Left Ventricular Noncompaction 8,Chronic Granulomatous Disease,Cleft Palate, Isolated,Body Mass Index Quantitative Trait Locus 11,Restrictive Cardiomyopathy,Adult T-Cell Leukemia,Myelodysplastic Syndrome,Granulomatous Disease, Chronic, X-Linked,Lipodystrophy, Familial Partial, Type 2,Chromosome 1p36 Deletion Syndrome,Left Ventricular Noncompaction |
2n1i_a | Q9HAZ2 | ENSG00000142611 | PRDM16 | 96.30 | 1.70E-05 | 1.60E-09 | 69.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR207C | SET5 | SGDID:S000001250 | PFAG_03779 |
PFAG_03779 |
Plasmodium falciparum | 4rz0_a | W7FLI1 | 97.00 | 1.00E-06 | 9.80E-11 | 74.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YHR207C | SET5 | SGDID:S000001250 | EZH2 KMT6 |
Histone-lysine N-methyltransferase EZH2 (EC 2.1.1.356) (ENX-1) (Enhancer of zeste homolog 2) (Lysine N-methyltransferase 6) |
2.1.1.356 | Homo sapiens | Skin Melanoma,Retinitis Pigmentosa,Cll/Sll,Chronic Myelomonocytic Leukemia,Melanoma,Breast Myoepithelial Carcinoma,Clear Cell Renal Cell Carcinoma,Diffuse Midline Glioma, H3 K27m-Mutant,B-Cell Lymphoma,Atypical Teratoid Rhabdoid Tumor,Essential Thrombocythemia,Posterior Fossa Ependymoma,Cholangiolocellular Carcinoma,Neuroblastoma,Primary Cutaneous Follicle Center Lymphoma,Leukemia, Acute Myeloid,Secondary Hemophagocytic Lymphohistiocytosis,Bone Marrow Cancer,Transitional Cell Carcinoma,Ezh2-Related Overgrowth,Bladder Cancer,Bile Duct Adenoma,Primary Hyperoxaluria,Ovarian Cancer,T-Cell Acute Lymphoblastic Leukemia,Breast Cancer,Colorectal Cancer,Hepatocellular Carcinoma,Malignant Peripheral Nerve Sheath Tumor,Rhabdomyosarcoma,Weaver Syndrome,Tongue Disease,Sotos Syndrome 1,Gastric Cancer,Breast Adenocarcinoma,Prostate Cancer,Disease Of Mental Health,Cholangiocarcinoma,Rhabdoid Cancer,Fragile X Syndrome,Lymphoma, Non-Hodgkin, Familial,Beckwith-Wiedemann Syndrome,Esophageal Cancer,Myelodysplastic Syndrome,Diffuse Large B-Cell Lymphoma,Ewing Sarcoma,Mantle Cell Lymphoma,Splenic Marginal Zone Lymphoma,Tongue Squamous Cell Carcinoma,Acute Promyelocytic Leukemia,Follicular Lymphoma,Ovarian Clear Cell Carcinoma,Nasopharyngeal Carcinoma,Lymphoma,Brain Glioma,Kabuki Syndrome 1,Juvenile Myelomonocytic Leukemia,Autosomal Dominant Non-Syndromic Intellectual Disability,Rett Syndrome,Myelofibrosis,Myeloma, Multiple,Medulloblastoma,Melanoma, Uveal,Childhood Acute Myeloid Leukemia,Lung Cancer,Hyperoxaluria, Primary, Type I,Pancreatic Cancer,Polycythemia Vera |
4mi5_a | Q15910 | ENSG00000106462 | EZH2 | 96.70 | 4.60E-06 | 4.20E-10 | 77.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR207C | SET5 | SGDID:S000001250 | dim-5 29E8.110 NCU04402 |
Histone-lysine N-methyltransferase, H3 lysine-9 specific dim-5 (EC 2.1.1.355) (Histone H3-K9 methyltransferase dim-5) (H3-K9-HMTase dim-5) (HKMT) |
2.1.1.355 | Neurospora crassa | 1peg_a | Q8X225 | 97.60 | 4.20E-08 | 3.80E-12 | 95.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YHR207C | SET5 | SGDID:S000001250 | CTHT_0006210 |
CTHT_0006210 |
Chaetomium thermophilum | 5kkl_b | G0RYC6 | ENSG00000275714 | H3C1 | 96.30 | 2.20E-05 | 1.80E-09 | 87.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
YHR207C | SET5 | SGDID:S000001250 | SET1 KLLA0F24134g |
Histone-lysine N-methyltransferase, H3 lysine-4 specific (EC 2.1.1.354) (COMPASS component SET1) (SET domain-containing protein 1) |
2.1.1.354 | Kluyveromyces lactis | 6chg_c | Q6CIT4 | 97.50 | 7.50E-08 | 7.30E-12 | 82.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YHR207C | SET5 | SGDID:S000001250 | SMYD3 ZMYND1 ZNFN3A1 |
Histone-lysine N-methyltransferase SMYD3 (EC 2.1.1.354) (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1) |
2.1.1.354 | Homo sapiens | Cerebellar Ataxia, Nonprogressive, With Mental Retardation,Renal Wilms' Tumor,Hepatocellular Carcinoma |
5v37_a | Q9H7B4 | ENSG00000185420 | SMYD3 | 99.80 | 1.20E-25 | 1.20E-29 | 225.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR207C | SET5 | SGDID:S000001250 | KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 |
Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.354) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] |
2.1.1.354 | Homo sapiens | Childhood Acute Lymphocytic Leukemia,Lymphoblastic Lymphoma,Hypertrichosis,Chronic Neutrophilic Leukemia,Chronic Myelomonocytic Leukemia,Cornelia De Lange Syndrome,Leukemia, Chronic Myeloid,Acute Myeloid Leukemia With T(9;11)(P22;Q23),B-Lymphoblastic Leukemia/Lymphoma,B-Lymphoblastic Leukemia/Lymphoma With Bcr-Abl1,B-Lymphoblastic Leukemia/Lymphoma With Iamp21,Rare Genetic Intellectual Disability,Myeloproliferative Neoplasm,Leukemia,Pancytopenia,Mixed Phenotype Acute Leukemia,Childhood Leukemia,Acute Leukemia,Leukemia, Acute Myeloid,Acute Myeloid Leukemia With 11q23 Abnormalities,Intravascular Large B-Cell Lymphoma,Familial Isolated Trichomegaly,Myelodysplastic/Myeloproliferative Neoplasm,Hematologic Cancer,Leukemia, Acute Lymphoblastic,Ring Chromosome 21,Acute Megakaryoblastic Leukemia Without Down Syndrome,Rubinstein Taybi Like Syndrome,Central Nervous System Leukemia,Monocytic Leukemia,Ring Chromosome,Myeloid Sarcoma,Myeloid Leukemia,Acute Megakaryocytic Leukemia,Acute Monoblastic Leukemia,Colon Leiomyoma,Cytogenetically Normal Acute Myeloid Leukemia,Microcephaly,Hypoxia,Chronic Granulomatous Disease,Alacrima, Achalasia, And Mental Retardation Syndrome,Leukemia, Acute Lymphoblastic 3,Disease Of Mental Health,Cornelia De Lange Syndrome 1,Lymphoma, Non-Hodgkin, Familial,Wiedemann-Steiner Syndrome,Myelodysplastic Syndrome,Hairy Elbows,Acute Promyelocytic Leukemia,Wilms Tumor 1,Kabuki Syndrome 1,Kbg Syndrome,Leukemia, Acute Monocytic,Leukemia, Chronic Lymphocytic,Juvenile Myelomonocytic Leukemia,Autosomal Dominant Non-Syndromic Intellectual Disability,Autism |
5f5e_a | Q03164 | ENSG00000118058 | KMT2A | 97.60 | 4.40E-08 | 4.20E-12 | 84.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR207C | SET5 | SGDID:S000001250 | SUVH6 SDG23 SET23 At2g22740 T9I22.18 |
Histone-lysine N-methyltransferase, H3 lysine-9 specific SUVH6 (EC 2.1.1.-) (Histone H3-K9 methyltransferase 6) (H3-K9-HMTase 6) (Protein SET DOMAIN GROUP 23) (Suppressor of variegation 3-9 homolog protein 6) (Su(var)3-9 homolog protein 6) |
2.1.1.- | Arabidopsis thaliana | 6a5k_a | Q8VZ17 | 97.40 | 1.40E-07 | 1.20E-11 | 99.40 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||
YHR207C | SET5 | SGDID:S000001250 | SUVH9 SDG22 SET22 At4g13460 T6G15.10 |
Histone-lysine N-methyltransferase family member SUVH9 (Histone H3-K9 methyltransferase 9) (H3-K9-HMTase 9) (Protein SET DOMAIN GROUP 22) (Suppressor of variegation 3-9 homolog protein 9) (Su(var)3-9 homolog protein 9) |
Arabidopsis thaliana | 4nj5_a | Q9T0G7 | 96.70 | 4.20E-06 | 3.60E-10 | 87.80 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | ||||
YHR207C | SET5 | SGDID:S000001250 | SET1 SCY_2511 |
SET1 SCY_2511 |
2.1.1.354 | Saccharomyces cerevisiae | 6bx3_e | A6ZT27 | 97.30 | 2.00E-07 | 1.70E-11 | 90.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YHR207C | SET5 | SGDID:S000001250 | cgd4_370 |
cgd4_370 |
Cryptosporidium parvum | 4ldg_a | Q5CQK4 | 96.60 | 5.80E-06 | 5.00E-10 | 80.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YHR207C | SET5 | SGDID:S000001250 | PRDM12 PFM9 |
PR domain zinc finger protein 12 (EC 2.1.1.-) (PR domain-containing protein 12) |
2.1.1.- | Homo sapiens | Factitious Disorder,Familial Episodic Pain Syndrome,Neuropathy,Paroxysmal Extreme Pain Disorder,Neurogenic Arthropathy,Neuropathy, Hereditary Sensory And Autonomic, Type Viii |
3ep0_b | Q9H4Q4 | ENSG00000130711 | PRDM12 | 96.50 | 8.00E-06 | 7.40E-10 | 71.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR207C | SET5 | SGDID:S000001250 | PRDM1 BLIMP1 |
PR domain zinc finger protein 1 (EC 2.1.1.-) (BLIMP-1) (Beta-interferon gene positive regulatory domain I-binding factor) (PR domain-containing protein 1) (Positive regulatory domain I-binding factor 1) (PRDI-BF1) (PRDI-binding factor 1) |
2.1.1.- | Homo sapiens | Primary Cutaneous B-Cell Lymphoma,Mature B-Cell Neoplasm,B-Cell Lymphoma,Common Variable Immunodeficiency,Plasmablastic Lymphoma,Monoclonal Paraproteinemia,Mulchandani-Bhoj-Conlin Syndrome,Burkitt Lymphoma,Central Nervous System Lymphoma,Anorectal Stricture,Fanconi Anemia, Complementation Group A,Plasmacytoma,Inflammatory Bowel Disease,Diffuse Large B-Cell Lymphoma,Mantle Cell Lymphoma,Hashimoto Thyroiditis,Lymphoma,Systemic Lupus Erythematosus,Oral Hairy Leukoplakia,Myeloma, Multiple |
3dal_a | O75626 | ENSG00000057657 | PRDM1 | 97.10 | 7.90E-07 | 7.30E-11 | 80.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR207C | SET5 | SGDID:S000001250 | KMT2E MLL5 |
Inactive histone-lysine N-methyltransferase 2E (Inactive lysine N-methyltransferase 2E) (Myeloid/lymphoid or mixed-lineage leukemia protein 5) |
Homo sapiens | Epilepsy,Non-Specific Syndromic Intellectual Disability,Kleefstra Syndrome 2,Disease Of Mental Health,O'Donnell-Luria-Rodan Syndrome,Cerebroretinal Microangiopathy With Calcifications And Cysts 1,Kabuki Syndrome 1,Agenesis Of Corpus Callosum, Cardiac, Ocular, And Genital Syndrome,Autism |
5ht6_a | Q8IZD2 | ENSG00000005483 | KMT2E | 96.50 | 7.50E-06 | 7.30E-10 | 68.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YHR207C | SET5 | SGDID:S000001250 | ASH1L KIAA1420 KMT2H |
Histone-lysine N-methyltransferase ASH1L (EC 2.1.1.359) (EC 2.1.1.367) (ASH1-like protein) (huASH1) (Absent small and homeotic disks protein 1 homolog) (Lysine N-methyltransferase 2H) |
2.1.1.359 | Homo sapiens | Facioscapulohumeral Muscular Dystrophy 1,Sotos Syndrome 1,Pulpitis,Mental Retardation, Autosomal Dominant 52,Autism Spectrum Disorder,Autosomal Dominant Non-Syndromic Intellectual Disability,Autism |
4ynm_a | Q9NR48 | ENSG00000116539 | ASH1L | 97.70 | 2.10E-08 | 1.90E-12 | 93.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR207C | SET5 | SGDID:S000001250 | KMT5B SUV420H1 CGI-85 |
Histone-lysine N-methyltransferase KMT5B (Lysine N-methyltransferase 5B) (Lysine-specific methyltransferase 5B) (Suppressor of variegation 4-20 homolog 1) (Su(var)4-20 homolog 1) (Suv4-20h1) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.361) |
2.1.1.361,2.1.1.362, | Homo sapiens | Primary Hyperoxaluria,Meier-Gorlin Syndrome 1,Mental Retardation, Autosomal Dominant 51,Autism Spectrum Disorder,Autism,Hyperoxaluria, Primary, Type I |
3s8p_a | Q4FZB7 | ENSG00000110066 | KMT5B | 97.70 | 1.80E-08 | 1.60E-12 | 97.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR207C | SET5 | SGDID:S000001250 | SETD2 HIF1 HYPB KIAA1732 KMT3A SET2 HSPC069 |
Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.359) (HIF-1) (Huntingtin yeast partner B) (Huntingtin-interacting protein 1) (HIP-1) (Huntingtin-interacting protein B) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2) (hSET2) (p231HBP) |
2.1.1.359 | Homo sapiens | Peritoneum Cancer,Lung Cancer Susceptibility 3,Collecting Duct Carcinoma,Clear Cell Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Corpus Callosum, Agenesis Of,Enteropathy-Associated T-Cell Lymphoma,Retinal Ischemia,Acute Leukemia,Leukemia, Acute Myeloid,Leukemia, Acute Lymphoblastic,Kidney Cancer,Dandy-Walker Syndrome,Acute Megakaryoblastic Leukemia Without Down Syndrome,Intellectual Disability - Hypoplastic Corpus Callosum - Preauricular Tag,Brain Cancer,Squamous Cell Carcinoma, Head And Neck,Colorectal Cancer,Age-Related Hearing Loss,Pheochromocytoma,Weaver Syndrome,Hepatosplenic T-Cell Lymphoma,Sotos Syndrome 1,Prostate Cancer,Renal Cell Carcinoma, Papillary, 1,Hydrocephalus, Congenital, 1,Renal Cell Carcinoma, Nonpapillary,Uterine Corpus Endometrial Carcinoma,Wolf-Hirschhorn Syndrome,Autism Spectrum Disorder,Luscan-Lumish Syndrome,Autism,Lung Cancer |
5jlb_a | Q9BYW2 | ENSG00000181555 | SETD2 | 97.40 | 1.10E-07 | 9.30E-12 | 92.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR207C | SET5 | SGDID:S000001250 | clr4 kmt1 SPBC428.08c |
Histone-lysine N-methyltransferase, H3 lysine-9 specific (EC 2.1.1.355) (Cryptic loci regulator 4) (Histone H3-K9 methyltransferase) (H3-K9-HMTase) (HKMT) (Lysine N-methyltransferase 1) (Protein lysine methyltransferase clr4) (PKMT) |
2.1.1.355 | Schizosaccharomyces pombe | 6bp4_b | O60016 | 97.40 | 1.20E-07 | 1.00E-11 | 92.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YHR207C | SET5 | SGDID:S000001250 | KMT5C SUV420H2 PP7130 |
Histone-lysine N-methyltransferase KMT5C (Lysine N-methyltransferase 5C) (Lysine-specific methyltransferase 5C) (Suppressor of variegation 4-20 homolog 2) (Su(var)4-20 homolog 2) (Suv4-20h2) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.361) |
2.1.1.361,2.1.1.362, | Homo sapiens | Primary Hyperoxaluria,Hyperoxaluria, Primary, Type I |
3rq4_a | Q86Y97 | ENSG00000133247 | KMT5C | 97.80 | 1.30E-08 | 1.10E-12 | 96.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR207C | SET5 | SGDID:S000001250 | KMT5A PRSET7 SET07 SET8 SETD8 |
N-lysine methyltransferase KMT5A (EC 2.1.1.-) (H4-K20-HMTase KMT5A) (Histone-lysine N-methyltransferase KMT5A) (EC 2.1.1.361) (Lysine N-methyltransferase 5A) (Lysine-specific methylase 5A) (PR/SET domain-containing protein 07) (PR-Set7) (PR/SET07) (SET domain-containing protein 8) |
2.1.1.361 | Homo sapiens | Meier-Gorlin Syndrome 1 |
3f9x_c | Q9NQR1 | ENSG00000183955 | KMT5A | 96.70 | 4.30E-06 | 4.10E-10 | 72.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR207C | SET5 | SGDID:S000001250 | Kmt5b Suv420h1 |
Histone-lysine N-methyltransferase KMT5B (Lysine-specific methyltransferase 5B) (Suppressor of variegation 4-20 homolog 1) (Su(var)4-20 homolog 1) (Suv4-20h1) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.361) |
2.1.1.361,2.1.1.362, | Mus musculus | 4bup_b | Q3U8K7 | 97.70 | 2.40E-08 | 2.10E-12 | 96.80 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YHR207C | SET5 | SGDID:S000001250 | EHMT2 BAT8 C6orf30 G9A KMT1C NG36 |
Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) |
2.1.1.- | Homo sapiens | Kleefstra Syndrome,Choline Deficiency Disease,Brain Cancer,Cockayne Syndrome,Primary Hyperoxaluria,Carbohydrate Metabolic Disorder,Prader-Willi Syndrome,Disease Of Mental Health,Kleefstra Syndrome 1,Basan Syndrome,Hyperoxaluria, Primary, Type I |
5tuy_a | Q96KQ7 | ENSG00000204371 | EHMT2 | 97.30 | 2.00E-07 | 1.80E-11 | 89.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR207C | SET5 | SGDID:S000001250 | KMT2D ALR MLL2 MLL4 |
Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.354) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2) |
2.1.1.354 | Homo sapiens | Charge Syndrome,Plasma Cell Neoplasm,Cold Agglutinin Disease,Kleefstra Syndrome,Cavernous Sinus Meningioma,Rasopathy,Holoprosencephaly,Hypoplastic Left Heart Syndrome,Leukemia, Acute Myeloid,Dandy-Walker Syndrome,Rubinstein Taybi Like Syndrome,Breast Malignant Phyllodes Tumor,Microphthalmia,Microcephaly,Weaver Syndrome,Sotos Syndrome 1,Alacrima, Achalasia, And Mental Retardation Syndrome,Fanconi Anemia, Complementation Group A,Disease Of Mental Health,Complement Component C1s Deficiency,Chromosome 16p13.3 Deletion Syndrome, Proximal,Mental Retardation, Autosomal Dominant 26,Childhood Medulloblastoma,Lung Squamous Cell Carcinoma,Smith-Magenis Syndrome,Spinocerebellar Ataxia 2,Tetralogy Of Fallot,Peripheral T-Cell Lymphoma,Congenital Disorder Of Glycosylation, Type Ig,Autism Spectrum Disorder,Lymphoma,Kabuki Syndrome 1,Kbg Syndrome,Methylmalonic Acidemia And Homocysteinemia, Cblx Type,Scoliosis,Autosomal Dominant Non-Syndromic Intellectual Disability,Myeloma, Multiple,Medulloblastoma,Isolated Growth Hormone Deficiency Type Iii,Postaxial Acrofacial Dysostosis |
4z4p_a | O14686 | ENSG00000167548 | KMT2D | 97.60 | 4.80E-08 | 4.60E-12 | 85.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR207C | SET5 | SGDID:S000001250 | Kmt5c Suv420h2 |
Histone-lysine N-methyltransferase KMT5C (Lysine-specific methyltransferase 5C) (Suppressor of variegation 4-20 homolog 2) (Su(var)4-20 homolog 2) (Suv4-20h2) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.361) |
2.1.1.361,2.1.1.362, | Mus musculus | 4au7_a | Q6Q783 | 97.80 | 9.10E-09 | 8.10E-13 | 98.20 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YHR207C | SET5 | SGDID:S000001250 | EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D |
Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) |
2.1.1.- | Homo sapiens | Kleefstra Syndrome,Deafness, Autosomal Dominant 47,Hypoplastic Left Heart Syndrome,Polymicrogyria,Kleefstra Syndrome Due To A Point Mutation,Pontocerebellar Hypoplasia, Type 2a,Weaver Syndrome,Sotos Syndrome 1,Alacrima, Achalasia, And Mental Retardation Syndrome,Disease Of Mental Health,Kleefstra Syndrome 1,Chromosome 16p13.3 Deletion Syndrome, Proximal,Pitt-Hopkins Syndrome,Schizophrenia,Ogden Syndrome,Autism Spectrum Disorder,Kabuki Syndrome 1,Autosomal Dominant Non-Syndromic Intellectual Disability,Chromosomal Deletion Syndrome,Autism,Christianson Syndrome |
5vsf_a | Q9H9B1 | ENSG00000181090 | EHMT1 | 97.40 | 1.10E-07 | 1.00E-11 | 90.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR207C | SET5 | SGDID:S000001250 | set7 SPCC297.04c |
SET domain-containing protein 7 (EC 2.1.1.-) |
2.1.1.- | Schizosaccharomyces pombe | 5h6z_a | Q9Y7Q6 | 97.90 | 4.90E-09 | 4.70E-13 | 92.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YHR207C | SET5 | SGDID:S000001250 | PRDM2 KMT8 RIZ |
PR domain zinc finger protein 2 (EC 2.1.1.355) (GATA-3-binding protein G3B) (Lysine N-methyltransferase 8) (MTB-ZF) (MTE-binding protein) (PR domain-containing protein 2) (Retinoblastoma protein-interacting zinc finger protein) (Zinc finger protein RIZ) |
2.1.1.355 | Homo sapiens | Childhood Acute Lymphocytic Leukemia,Intrahepatic Bile Duct Adenoma,Breast Cancer,Hepatocellular Carcinoma,Gastric Cancer,Retinoblastoma,Myopathy, Proximal, With Ophthalmoplegia,Wilms Tumor 1,Meningioma, Familial,Medulloblastoma |
2jv0_a | Q13029 | ENSG00000116731 | PRDM2 | 96.30 | 1.90E-05 | 1.80E-09 | 68.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR207C | SET5 | SGDID:S000001250 | SETD7 KIAA1717 KMT7 SET7 SET9 |
Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.364) (Histone H3-K4 methyltransferase SETD7) (H3-K4-HMTase SETD7) (Lysine N-methyltransferase 7) (SET domain-containing protein 7) (SET7/9) |
2.1.1.364 | Homo sapiens | 1muf_a | Q8WTS6 | ENSG00000145391 | SETD7 | 96.70 | 3.80E-06 | 3.70E-10 | 77.40 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YHR207C | SET5 | SGDID:S000001250 | BN1205_038210 TGVEG_216080 |
BN1205_038210 TGVEG_216080 |
Toxoplasma gondii | 6fnd_b | B9Q0K5 | 99.10 | 1.90E-14 | 1.90E-18 | 143.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YHR207C | SET5 | SGDID:S000001250 | legAS4 lpg1718 |
legAS4 lpg1718 |
Legionella pneumophila | 5czy_a | Q5ZUS4 | 97.30 | 2.50E-07 | 2.40E-11 | 94.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YHR207C | SET5 | SGDID:S000001250 | SUV39H2 KMT1B |
Histone-lysine N-methyltransferase SUV39H2 (EC 2.1.1.355) (Histone H3-K9 methyltransferase 2) (H3-K9-HMTase 2) (Lysine N-methyltransferase 1B) (Suppressor of variegation 3-9 homolog 2) (Su(var)3-9 homolog 2) |
2.1.1.355 | Homo sapiens | Primary Hyperoxaluria,Carbohydrate Metabolic Disorder,Hyperoxaluria, Primary, Type I |
2r3a_a | Q9H5I1 | ENSG00000152455 | SUV39H2 | 97.40 | 1.30E-07 | 1.20E-11 | 92.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR207C | SET5 | SGDID:S000001250 | Smyd1 Bop |
Histone-lysine N-methyltransferase Smyd1 (EC 2.1.1.354) (CD8b-opposite) (SET and MYND domain-containing protein 1) (Zinc finger protein BOP) (m-BOP) |
2.1.1.354 | Mus musculus | 3n71_a | P97443 | 99.90 | 3.50E-27 | 3.50E-31 | 242.90 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YHR207C | SET5 | SGDID:S000001250 | SETD6 |
N-lysine methyltransferase SETD6 (EC 2.1.1.-) (SET domain-containing protein 6) |
2.1.1.- | Homo sapiens | Familial Colorectal Cancer Type X,Meningioma, Familial |
3qxy_a | Q8TBK2 | ENSG00000103037 | SETD6 | 98.80 | 5.90E-13 | 5.50E-17 | 137.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR207C | SET5 | SGDID:S000001250 | SMYD2 KMT3C |
N-lysine methyltransferase SMYD2 (EC 2.1.1.-) (HSKM-B) (Histone methyltransferase SMYD2) (EC 2.1.1.354) (Lysine N-methyltransferase 3C) (SET and MYND domain-containing protein 2) |
2.1.1.354 | Homo sapiens | 4wuy_a | Q9NRG4 | ENSG00000143499 | SMYD2 | 99.90 | 2.90E-28 | 2.90E-32 | 250.40 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YHR207C | SET5 | SGDID:S000001250 | SETMAR |
Histone-lysine N-methyltransferase SETMAR (SET domain and mariner transposase fusion protein) (Metnase) [Includes: Histone-lysine N-methyltransferase (EC 2.1.1.357); Transposon Hsmar1 transposase (EC 3.1.-.-)] |
2.1.1.357 | Homo sapiens | Meier-Gorlin Syndrome 1,Fanconi Anemia, Complementation Group A |
3bo5_a | Q53H47 | ENSG00000170364 | SETMAR | 97.50 | 7.50E-08 | 6.70E-12 | 93.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR207C | SET5 | SGDID:S000001250 | NSD3 WHSC1L1 DC28 |
Histone-lysine N-methyltransferase NSD3 (EC 2.1.1.370) (EC 2.1.1.371) (Nuclear SET domain-containing protein 3) (Protein whistle) (WHSC1-like 1 isoform 9 with methyltransferase activity to lysine) (Wolf-Hirschhorn syndrome candidate 1-like protein 1) (WHSC1-like protein 1) |
2.1.1.370,2.1.1.371, | Homo sapiens | Weaver Syndrome,Sotos Syndrome 1,Kleefstra Syndrome 1,Wolf-Hirschhorn Syndrome,Nut Midline Carcinoma,Childhood Acute Myeloid Leukemia |
6cen_a | Q9BZ95 | ENSG00000147548 | NSD3 | 97.50 | 9.70E-08 | 8.80E-12 | 89.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR207C | SET5 | SGDID:S000001250 | Cbfa2t2 Cbfa2t2h Mtgr1 |
Protein CBFA2T2 (MTG8-like protein) (MTG8-related protein 1) |
Mus musculus | 5ecj_b | O70374 | 97.60 | 3.30E-08 | 3.00E-12 | 96.90 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | ||||
YHR207C | SET5 | SGDID:S000001250 | SUVH4 KYP SDG33 SET33 At5g13960 MAC12.7 |
Histone-lysine N-methyltransferase, H3 lysine-9 specific SUVH4 (EC 2.1.1.-) (Histone H3-K9 methyltransferase 4) (H3-K9-HMTase 4) (Protein KRYPTONITE) (Protein SET DOMAIN GROUP 33) (Suppressor of variegation 3-9 homolog protein 4) (Su(var)3-9 homolog protein 4) |
2.1.1.- | Arabidopsis thaliana | 4qeo_a | Q8GZB6 | 97.30 | 2.10E-07 | 1.80E-11 | 98.30 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||
YHR207C | SET5 | SGDID:S000001250 | PRDM11 PFM8 |
PR domain-containing protein 11 (EC 2.1.1.-) |
2.1.1.- | Homo sapiens | Hermansky-Pudlak Syndrome 1 |
3ray_a | Q9NQV5 | 96.60 | 6.30E-06 | 5.70E-10 | 77.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |